SCHEMBL833039

SCHEMBL833039

COC(=O)C=Cc1ccc(NCCO)c([N+](=O)[O-])c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
TDP1 Q9NUW8 2/20 0.50
TSHR P16473 1/20 0.50
MAPT P10636 8/20 0.48
PKM P14618 3/20 0.48
MAPK1 P28482 2/20 0.48
RECQL P46063 1/20 0.48
HCAR3 P49019 2/20 0.48
MEN1 O00255 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.46
TTR P02766 1/20 0.46
APP P05067 1/20 0.46
MCL1 Q07820 1/20 0.46
RAB9A P51151 4/20 0.45
PTGER4 P35408 1/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 2/20 0.45
CRHBP P24387 1/20 0.45
CRHR2 Q13324 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL833038 1.00 ALDH1A1 (0.50) ALDH1A1TDP1TSHRMAPTPKM
SCHEMBL832815 0.89 MAPT (0.50) ALDH1A1TDP1MAPTPKMMAPK1
SCHEMBL830286 0.89 MAPT (0.53) ALDH1A1TDP1MAPTPKMMAPK1
SCHEMBL832816 0.89 MAPT (0.50) ALDH1A1TDP1MAPTPKMMAPK1
SCHEMBL830285 0.89 MAPT (0.53) ALDH1A1TDP1MAPTPKMMAPK1
SCHEMBL866627 0.88 MAPT (0.47) ALDH1A1TDP1MAPTPKMMAPK1
SCHEMBL834053 0.87 ALDH1A1 (0.57) ALDH1A1TDP1TSHRMAPTPKM
SCHEMBL832010 0.87 MAPT (0.46) ALDH1A1TDP1MAPTPKMMAPK1
SCHEMBL832011 0.87 MAPT (0.46) ALDH1A1TDP1MAPTPKMMAPK1
SCHEMBL834052 0.87 ALDH1A1 (0.57) ALDH1A1TDP1TSHRMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143282-B2 Heterocyclic compounds S*BIO PTE LTD. (SG) 2012-03-27 US disclosed
EP-1937650-B1 HETEROCYCLIC COMPOUNDS S BIO PTE LTD (SG) 2011-06-15 EP disclosed
US-20090048300-A1 Heterocyclic Compounds S*BIO PTE LTD. (SG) 2009-02-19 US disclosed
EP-1937650-A1 HETEROCYCLIC COMPOUNDS S*Bio Pte Ltd (SG) 2008-07-02 EP disclosed
WO-2007030080-A1 HETEROCYCLIC COMPOUNDS S*BIO PTE LTD (SG) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048300-A1 Heterocyclic Compounds HDAC1, HDAC3, HDAC11 ALDH1A1 343/4885TDP1 649/4885TSHR 3681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.